About FSHD Canada Foundation

Move To A Cure...
A Cure To Move

Funding research to help find a cure for Canadians who suffer from FSHD.

Mouse Model to Validate Drugs Targeting DUX4 Enhancer/Promoter Activity

Investigator: Yosuke Hiramuki, Ph.D. at the University of Nevada, Reno We created a mouse model to validate the effect of drugs targeting DUX4 gene expression in a whole living organism.…

Read More

Testing the efficacy of CRISPRi in FSHD2

Investigators: Takako Jones, PhD and Charis L. Himeda, PhD; University of Nevada, Reno School of Medicine The goal of this proposal is to test the utility of our CRISPR inhibition…

Read More

All-in-one CRISPR inhibition for FSHD1 and FSHD2

Investigator: Charis L. Himeda, PhD, Research Assistant Professor Research Institution: Peter Jones Lab, University of Nevada, Reno School of Medicine, Reno NV USA The most direct path to an FSHD…

Read More

Srideep Dey

Kitchener, ON

I was diagnosed with fshd at the age of 10, now I'm 23. I also face the same difficulties, among which climbing staircase is the worst, and I am scared…

Read More

Shanon

Spruce Grove, AB

I was a diagnosed at the age of 13 (1983). Neither of my parents have nor carry the gene. There is no family history. When I was 23, I had…

Read More

John Mora

Toronto, ON

Good evening, my name is John. I was diagnosed with FSHD Muscular Dystrophy on January of 2015. Before my diagnosis I used to train MMA and kickboxing, live a normal…

Read More

Our Mission

The singular goal of the FSHD Canada Foundation is to help find a cure — as soon as possible — for Canadians who suffer with FSHD.

To accomplish this the Foundation aims to reach out to all Canadians to make them aware of what is going on in FSHD research and to solicit financial support for the critical research required to find a cure. The Foundation will then use these funds to support FSHD research — in Canada and around the world.

Learn More

What is FSHD?

Facioscapulohumeral muscular dystrophy or FSHD is the most prevalent of the nine primary types of muscular dystrophy affecting adults and children. Muscular dystrophy in general connotes a genetic, hereditary muscle disease that causes progressive muscle weakness. FSHD is also broadly characterized as a neuromuscular disease (NMD), as muscular dystrophy is a subset of NMD. Muscular dystrophies are alike in that they cause progressive skeletal muscle weakness, defects in the biochemical, physical and structural components of muscle, and the death of muscle cells and tissue. However, researchers believe that the causes of each of the muscular dystrophies are not necessarily the same.

Learn More

https://twitter.com/#!/FSHDCanada/ http://www.facebook.com/pages/FSHD-Canada/331378503625267 /contact Suite 201, 1100 1st St. SE Calgary, Alberta T2G 1B1 403.470.0141 neil.camarta@fshd.ca